173 related articles for article (PubMed ID: 26325005)
1. BP1 overexpression is associated with adverse prognosis in de novo acute myeloid leukemia.
Zhou JD; Yang J; Guo H; Deng ZQ; Wen XM; Yang L; Yin JY; Xiao GF; Lin J; Qian J
Leuk Lymphoma; 2016; 57(4):828-34. PubMed ID: 26325005
[TBL] [Abstract][Full Text] [Related]
2. DLX4 hypermethylation is a prognostically adverse indicator in de novo acute myeloid leukemia.
Zhou JD; Zhang TJ; Wang YX; Yang DQ; Yang L; Ma JC; Wen XM; Yang J; Lin J; Qian J
Tumour Biol; 2016 Jul; 37(7):8951-60. PubMed ID: 26753961
[TBL] [Abstract][Full Text] [Related]
3. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation-mediated differential expression of DLX4 isoforms has opposing roles in leukemogenesis.
Zhou JD; Zhao YJ; Leng JY; Gu Y; Xu ZJ; Ma JC; Wen XM; Lin J; Zhang TJ; Qian J
Cell Mol Biol Lett; 2022 Jul; 27(1):59. PubMed ID: 35883028
[TBL] [Abstract][Full Text] [Related]
5. Low SOX17 expression: prognostic significance in de novo acute myeloid leukemia with normal cytogenetics.
Tang CY; Lin J; Qian W; Yang J; Ma JC; Deng ZQ; Yang L; An C; Wen XM; Zhang YY; Qian J
Clin Chem Lab Med; 2014 Dec; 52(12):1843-50. PubMed ID: 24955525
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of BAALC: clinical significance in Chinese de novo acute myeloid leukemia.
Zhou JD; Yang L; Zhang YY; Yang J; Wen XM; Guo H; Yao DM; Ma JC; Chen Q; Lin J; Qian J
Med Oncol; 2015 Jan; 32(1):386. PubMed ID: 25428390
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of pseudogene Vimentin 2p is associated with poor outcome in de novo acute myeloid leukemia.
Zhai LL; Zhou J; Zhang J; Tang X; Zhou LY; Yin JY; Vanessa MD; Peng W; Lin J; Deng ZQ
Cancer Biomark; 2017; 18(3):305-312. PubMed ID: 28106537
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of miR-216b: Prognostic and predictive value in acute myeloid leukemia.
Zhang TJ; Wu DH; Zhou JD; Li XX; Zhang W; Guo H; Ma JC; Deng ZQ; Lin J; Qian J
J Cell Physiol; 2018 Apr; 233(4):3274-3281. PubMed ID: 28884855
[TBL] [Abstract][Full Text] [Related]
9. TET2 expression is a potential prognostic and predictive biomarker in cytogenetically normal acute myeloid leukemia.
Zhang TJ; Zhou JD; Yang DQ; Wang YX; Wen XM; Guo H; Yang L; Lian XY; Lin J; Qian J
J Cell Physiol; 2018 Aug; 233(8):5838-5846. PubMed ID: 29219176
[TBL] [Abstract][Full Text] [Related]
10. Low Expression of FUS1 Is Negatively Correlated with miR-378 and May Predict Adverse Prognoses in Acute Myeloid Leukemia.
Tang X; Zhou J; Zhang J; Zhou LY; Zhai LL; Vanessa ME; Yi J; Yi YY; Lin J; Deng ZQ
Acta Haematol; 2018; 139(2):89-95. PubMed ID: 29393096
[TBL] [Abstract][Full Text] [Related]
11. Low miR-34c expression is associated with poor outcome in de novo acute myeloid leukemia.
Yang DQ; Zhou JD; Wang YX; Deng ZQ; Yang J; Yao DM; Qian Z; Yang L; Lin J; Qian J
Int J Lab Hematol; 2017 Feb; 39(1):42-50. PubMed ID: 27577964
[TBL] [Abstract][Full Text] [Related]
12. Lower expression of bone marrow miR-122 is an independent risk factor for overall survival in cytogenetically normal acute myeloid leukemia.
Zhang TJ; Qian Z; Wen XM; Zhou JD; Li XX; Xu ZJ; Ma JC; Zhang ZH; Lin J; Qian J
Pathol Res Pract; 2018 Jun; 214(6):896-901. PubMed ID: 29627222
[TBL] [Abstract][Full Text] [Related]
13. BP1, a new homeobox gene, is frequently expressed in acute leukemias.
Haga SB; Fu S; Karp JE; Ross DD; Williams DM; Hankins WD; Behm F; Ruscetti FW; Chang M; Smith BD; Becton D; Raimondi SC; Berg PE
Leukemia; 2000 Nov; 14(11):1867-75. PubMed ID: 11069021
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of up-regulated ID1 expression in Chinese de novo acute myeloid leukemia.
Zhou JD; Yang L; Zhu XW; Wen XM; Yang J; Guo H; Chen Q; Yao DM; Ma JC; Lin J; Qian J
Int J Clin Exp Pathol; 2015; 8(5):5336-44. PubMed ID: 26191235
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of HOXB4 in de novo acute myeloid leukemia.
Umeda S; Yamamoto K; Murayama T; Hidaka M; Kurata M; Ohshima T; Suzuki S; Sugawara E; Kawano F; Kitagawa M
Hematology; 2012 May; 17(3):125-31. PubMed ID: 22664110
[TBL] [Abstract][Full Text] [Related]
16. Pseudogene BMI1P1 expression as a novel predictor for acute myeloid leukemia development and prognosis.
Zhou LY; Zhai LL; Yin JY; Vanessa ME; Zhou J; Zhang J; Tang X; Lin J; Qian J; Deng ZQ
Oncotarget; 2016 Jul; 7(30):47376-47386. PubMed ID: 27329719
[TBL] [Abstract][Full Text] [Related]
17. Low NKD1 expression predicts adverse prognosis in cytogenetically normal acute myeloid leukemia.
Zhou JD; Yao DM; Han L; Xiao GF; Guo H; Zhang TJ; Li XX; Yuan Q; Yang L; Lin J; Qian J
Tumour Biol; 2017 Apr; 39(4):1010428317699123. PubMed ID: 28443469
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of CTNNB1: Clinical implication in Chinese de novo acute myeloid leukemia.
Li XX; Guo H; Zhou JD; Wu DH; Ma JC; Wen XM; Zhang W; Xu ZJ; Lin J; Jun Q
Pathol Res Pract; 2018 Mar; 214(3):361-367. PubMed ID: 29496308
[TBL] [Abstract][Full Text] [Related]
19. [Expression of BP1 gene in adult acute leukemia].
Li H; Xu KL; Pan XY; Wang HY; Li ZY
Zhonghua Xue Ye Xue Za Zhi; 2004 Jan; 25(1):38-40. PubMed ID: 14990078
[TBL] [Abstract][Full Text] [Related]
20. DNMT3A intragenic hypomethylation is associated with adverse prognosis in acute myeloid leukemia.
Zhang YY; Yao DM; Zhu XW; Zhou JD; Ma JC; Yang J; Wen XM; Guo H; Lin J; Qian J
Leuk Res; 2015 Oct; 39(10):1041-7. PubMed ID: 26242829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
